Advancing Genetic Testing in Kidney Diseases: Report From a National Kidney Foundation Working Group

NKD has received research funding from Regulus, Janssen, and Vertex, consults for Otsuka and Natera, and is on the scientific advisory committee of the PKD Foundation. DLF is a full-time employee of the National Kidney Foundation, to which support for this work was provided as an independent grant from Alnylam, Nateria, Reata, Travere, and Vertex. NF has received grants from the National Institutes of Health unrelated to this work. MRP has received research support from Vertex. RJHS directs the Molecular Otolaryngology and Renal Research Laboratories, serves on an advisory board for Novartis, and has received funding from the NIDDK. AGG has received research funding from Natera. He serves as a consultant for Natera via a service contracts to Columbia University. AGG has served as an advisor to Actio Biosciences, Novartis, Travere and has stock options in Actio Biosciences. The remaining authors declare that they have no relevant financial interests. Declarations for other members of the working group are found in Item S2.